Cartesian Therapeutics
RNAC
#6809
Rank
C$0.69 B
Marketcap
$27.30
Share price
-1.30%
Change (1 day)
-3.88%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -C$0.36 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are C$47.93 Million. In 2023 the company made an earning of -C$0.34 Billion a decrease over its 2022 earnings that were of C$54.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.36 Billion3.84%
2023 -C$0.34 Billion-724%
2022 C$54.24 M-649.67%
2021 -C$9.87 Million-89.78%
2020 -C$96.62 Million25.06%
2019 -C$77.26 Million-15.68%
2018 -C$91.62 Million-0.43%
2017 -C$92.02 Million83.41%
2016 -C$50.17 Million44.3%
2015 -C$34.77 Million